Pharmaceuticals News
|
The drive for new medications addresses patient need and is the motor that keeps the pharmaceutical sector turning. To accelerate the drug discovery process, pharmaceutical organizations are turning to artificial intelligence.
|
|
New York City -
The company famous for its social sensitivity has decided that curing sick people simply reduces profits. Goldman Sachs, with a degree of insensitivity or perhaps just more grovelling to the rich, has come up with reasons for people to stay sick.
|
|
Digital transformation has affected many sectors of the economy, and this includes healthcare and related activities, such as new technologies. A new report signals some major changes coming for pharmaceuticals.
|
|
E-learning carries many advantages for companies, including delivering training remotely and with minimum disruption. One area of increased take-up is pharma. To understand how such training can be delivered, Laura Guardi of Pharmig explains.
|
|
Pharmaceutical companies are under pressure to reduce expenses while improving results. This is one reason why the sector is looking towards digital technologies. A company down this journey is life science business Merck & Co.
|
|
Berlin -
The impact and future of digitization along the value chain of the pharmaceutical industry have been discussed at a recent conference. The process of digital transformation presents both opportunities and threats for pharma.
|
|
Industry 4.0, especially the approaches of cyber-physical systems control and monitor activity through computer-based algorithms, are impacting on the bioprocessing sector as pharmaceuticals seek improved efficiencies.
|
|
Of the different sectors of the British economy affected by the U.K.’s impending exit from the European Union, the pharmaceutical sector is one of the most significant. This relates to the value of the market and the regulatory impact.
|
|
A new paradigm is taking place in the world of pharmaceuticals, with a shift away from re-used, re-washed and re-sterilized equipment and eastwards the adoption of single-use sterile systems.
|
|
New technologies, cloud computing, and wider use of risk assessment are among the continuing changes that are disrupting the pharmaceutical sector. Expect 2018 to see the pace of change to accelerate.
|
|
Oxford -
Pharmaceutical organizations need to embrace rapid methods in order to protect patients, obtain faster results, and help to address inventory issues. This was a key message delivered at the annual Pharmig conference.
|
|
Washington -
CaryRx is a pharmacy startup that has set out to rebuild the pharmacy concept from the ground up, through the use of a mobile app. To hear more about this next generation approach to pharmacies we spoke with company co-founder Areo Nazari.
|
|
Otocec -
Data integrity is necessary for ensuring the safety of medicine, helping to assure that release tests are correct and have not been corrupted. This was a key message at a recent Pharmig conference held in Slovenia.
|
|
Digital healthcare represents a fast-moving field. However, as a new survey indicates, job skills are creating unevenness within the field — and problems for the industry overall.
|
|
The next wave of digital health technology needs to focus on the patient experience, either in the way patients interact with technology or the way the use it. This is a key finding from a new report into the state of pharmaceuticals and healthcare.
|
|
The tenth PwC report into the ‘digital health IQ’ of looks at the state of companies operating in the pharmaceutical and life sciences sector and it shows a faster, although sometimes uneven, rate of adoption of healthcare technology.
|
|
London -
Searching for new types of drugs is a medical imperative. This is a complex task involving many types of diseases and chemical interactions. To assist with this process, Francis Crick Institute researchers have developed a new model.
|
|
When it comes to supply chain practices, pharmaceuticals must address the normal concerns of customer satisfaction and the control goods as well as strict regulatory requirements. To better produce medicines, a new high-tech sensor has been developed.
|
|
Pharmaceutical companies are showing an increased interest in big data, focused on areas like drug discovery and with a realization this can give them a competitive advantage. This might not come so easily, however, without a joined-up strategy.
|
|
Pharmaceutical organizations are increasingly reliant upon automated systems and computers, from manufacturing to laboratory release testing. This has brought a renewed regulatory focus on the subject of data integrity.
|
|
Washington -
The company Quascenta has simplified cleaning validation for active pharmaceutical ingredient manufacturers through a new software package called eResidue. Cleaning validation is a key process, and it avoids cross-contamination.
|
|
University of California San Diego School of Medicine have completed an early phase clinical trial to evaluate the effectiveness of an established drug for the treatment of autism.
|
|
Bethesda -
A brand of herbal coffee has been recalled from the market after it was discovered that the product contained an unintended active pharmaceutical ingredient, designed to control erectile dysfunction.
|
|
Dublin -
Microbiologists from a range of pharmaceutical and healthcare companies convened in Dublin to attend a conference discussing how to effectively monitor the built environment for risks in relation to drug product manufacturing.
|
|
Birmingham -
The manufacture of medicines is at risk from cross-contamination from people, a result of the shedding of microorganisms. In February a special two-day conference considered how best to manage this risk.
|
|
Concerns over the proliferation of synthetic chemicals and pesticides, in particular, gave rise to the environmental movement in the 1960s. But scientific analysis of synthetic chemical pollution and their ecological impacts is disproportionately low.
|
|
Vermont -
The belief that most drugs in sewage are stashes of illegal narcotics flushed down toilets by criminals appears to be a myth. Most drugs in sewage systems are excreted by people who have been prescribed them.
|
|
In the latest pharmaceutical news round-up there is a new push to eliminate polio, a new treatment for COPD, and unfortunate news that a patient has died after taking an anti-psychotic medication.
|
|
India wants to get in on the oil-for-loans deal that Venezuela has with China, in the hopes of recouping some of the millions of dollars in payments owed to India's largest pharmaceutical companies.
|
|
As we do on a regular basis, Digital Journal has reviewed the latest developments within the pharmaceutical sector. Here AstraZeneca completes takeover of Takeda's respiratory business and Ferring Pharmaceuticals have a new nocturia treatment.
|
apis-363635 apis-363534 apis-363064 apis-362058 apis-362585 apis-361780 apis-361032 apis-358756 apis-354313 apis-353837 apis-352024 apis-350629 apis-348871 apis-346127 apis-346123 apis-346122 apis-342725 apis-342596 apis-340359 apis-340356 apis-340152 apis-336370 apis-336296 apis-335846 apis-327862 apis-326614 apis-315552 apis-306286 apis-306274 apis-305420
Pharmaceuticals Image
Biogen is an American global biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide. Biogen
Medicine vials on display at making Pharmaceuticals 2015.
Pharmaceutical manufacturing at BPL, Elstree, UK.
A variety of statin drugs
Sativex contains marijuana-derived ingredients. Associated Press
U.S. drug company sues Canada for trying to lower cost of $700K-a-year drug Alexion Pharmaceuticals
Dr. Olumayokun Olajide's research will now look to produce compound derivatives of punicalagin for a drug that would treat neuro-inflammation, slowing down the progression of Alzheimer's University of Huddersfield
Project Team at work: Expertise helps AbbVie develop and enhance products and therapies to treat conditions including HIV, arthritis, immunological and metabolic disorders, heart disease, and cancer. © AbbVie Inc.
Eli Lilly's global headquarters, Indianapolis, Indiana Guanaco152003
|
|
